Sun Pharma to Acquire Checkpoint Therapeutics ...Middle East

PR Newswire - News
Sun Pharma to Acquire Checkpoint Therapeutics

Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise Will leverage Sun Pharma's global presence to accelerate patient access to...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Sun Pharma to Acquire Checkpoint Therapeutics )

    Also on site :